AUG 10, 2016 3:14 PM PDT

One Drug to Take Down 3 Deadly Parasites?

WRITTEN BY: Xuan Pham
Pharmaceutical giant Novartis announced drastic and fruitful measures to combat three killer parasites that affect millions of people worldwide. After screening a whopping 3 million chemical compounds, they landed on a single drug that can kill parasites causing sleeping sickness, Chagas disease, and Leishmaniasis.
 
"What makes it special is the fact it is targeting all three parasites. That's the first time it has been done, so it is quite special,” said Elmarie Myburgh, co-author of the study published as a Letter in Nature.
 
Worldwide, around 20 million people are affected with sleeping sickness (via Trypanosoma brucei), Chagas disease (via Trypansosoma cruzi), and Leishmaniasis (via Leishmania). All three parasites share similar biology and genomic sequence, which prompted the quest for a common drug.
 
Indeed, scientists from the Genomics Institute of the Novartis Research Foundation combed through 3 million compounds – no small feat by any stretch of the imagination. Their persistence paid off when they finally found one compound that killed multiple parasites in the lab. Known as GNF6702 for now, the drug targets the parasites’ proteasomes – structures that chew up and recycle damaged or waste proteins in the cells.
 
Even if it can kill all the parasites, a drug is no good if it also kills the host cells indiscriminately. Luckily, in experiments, the team showed the drug inhibits the parasites’ proteasomes without affecting those of mammalian cells.
 
With modifications, the drug was made even more potent – 20 times more potent to be exact. But this seemed to be tolerated with no problem in mice, giving hope that pre-clinical and clinical trials will also show promising results.
 

"To me this is obviously a big deal, I'm in this field to try and make a difference, to get to a cure, and we're working hard in the hope that it gets to patients,” said Myburgh. "There's been very little incentive to spend a lot of money on these diseases as they affect a very poor, and yet large, population."
 
Drugs that are available currently to combat these infections have big limitations. Chief among them are cost, ease of use, and toxicity. That GNF6702 may overcome these limitations and treats three diseases simultaneously gives great hope to the millions of people affected and millions more at risk for these diseases. 

Additional source: Genomics Institute of the Novartis Research Foundation, BBC
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 15, 2021
Technology
Raman Spectroscopy Helps Track IBD Patient Response to Treatment
JUL 15, 2021
Raman Spectroscopy Helps Track IBD Patient Response to Treatment
While there have been multiple methods of evaluating whether a patient with inflammatory bowel disease (IBD) is respondi ...
JUL 21, 2021
Microbiology
What Causes False Positives? Understanding Blood Culture Contamination
JUL 21, 2021
What Causes False Positives? Understanding Blood Culture Contamination
Blood culture is the most widely used diagnostic tool for the detection of bacteremia and fungemia. It is the most impor ...
JUL 19, 2021
Cardiology
Immune Proteins & Blood Clots May be Connected to Psychosis Development
JUL 19, 2021
Immune Proteins & Blood Clots May be Connected to Psychosis Development
Researchers are pointing out the associations between blood clotting disruptions and the front line immune system, and t ...
AUG 04, 2021
Clinical & Molecular DX
Fear of Smells Could Help Diagnose Migraines in Kids
AUG 04, 2021
Fear of Smells Could Help Diagnose Migraines in Kids
  A new study suggests the intense dislike of pungent smells and odors could be a diagnostic marker for migraines a ...
AUG 17, 2021
Clinical & Molecular DX
Sleep Apnea Doubles the Risk of Sudden Death
AUG 17, 2021
Sleep Apnea Doubles the Risk of Sudden Death
Obstructive sleep apnea, or OSA, is the most commonly reported sleep disorder, with loud snoring being one of the tell-t ...
SEP 16, 2021
Clinical & Molecular DX
Your T-Shirt Could Soon Tell You if Your Heart Is Ok
SEP 16, 2021
Your T-Shirt Could Soon Tell You if Your Heart Is Ok
Forget uncomfortable chest straps or clunky wristbands—thanks to a new innovation in nanotechnology, your t-shirt ...
Loading Comments...